PredictND was a four-year, €4.2m European project funded by the EU’s 7th Framework Programme that drew to a close in 2018. It focused on developing tools and means for earlier, evidence-based diagnosis of a range of neurodegenerative diseases.
PredictND was coordinated by VTT Technical Research Centre of Finland Ltd. (Finland), and the consortium members included Alzheimer Europe (Luxembourg), Combinostics Ltd. (Finland), GE Healthcare (UK, Sweden), Imperial College of London (UK), Rigshospitalet (Denmark), Università degli Studi di Perugia (Italy), University of Eastern Finland (Finland) and VU/VUmc (the Netherlands). The collaboration is still very productive and continues to publish data from the project.
BrainStem – Stem Cell Center of Excellence in Neurology
BrainStem – Stem Cell Center of Excellence in Neurology is supported by Innovation Fund Denmark. The project coordinator is Professor Poul Hyttel, University of Copenhagen, and its primary partners are the University of Copenhagen, DDRC at Rigshospitalet, University of Southern Denmark, Aarhus University, Bioneer, Lundbeck A/S (Denmark), Lund University (Sweden) and Innovative Concepts in Drug Development (France).
Advanced stem cell technologies are used to re-programme skin cells from patients with AD and Parkinson’s disease to diseased neurons to study the underlying molecular mechanisms in order to develop better diagnostics and to test new drugs.
Joint Programming on Neurodegenerative Diseases (JPND)
JPNE, funded by Horizon 2020 and EU member states, is an innovative, collaborative research initiative established to tackle neurodegenerative diseases. DDRC has taken part in three JPND-funded research consortia on biomarkers in AD and Parkinson’s disease (BIOMARKAPD), on the definition of outcome measures in dementia and on the harmonisation of assessment methods.